New Therapeutic Opportunities in Dermatology: Low Dose Cytokines Treatment for Vitiligo
produce melanin via up-regulation of transmembrane receptors through SKA low dose basic-Fibroblast Growth Factor, represents the proposed Low Dose Medicine approach for Vitiligo treatment

